| Change in substantial holding | Nov 19, 2026 | Ownership change notice | ASX |
|---|
| Annual General Meeting Proxy Form | Oct 16, 2026 | Meeting notice | ASX |
|---|
| Notice of Annual General Meeting | Oct 16, 2026 | Meeting notice | ASX |
|---|
| Chair Transition | Oct 16, 2026 | Other filings | ASX |
|---|
| Change in substantial holding | Sep 28, 2026 | Ownership change notice | ASX |
|---|
| Notification of cessation of securities - SOM | Sep 4, 2026 | Financing | ASX |
|---|
| Change of Director's Interest Notice | Aug 28, 2026 | Ownership change notice | ASX |
|---|
| Change of Director's Interest Notice | Aug 28, 2026 | Ownership change notice | ASX |
|---|
| Change of Director's Interest Notice | Aug 28, 2026 | Ownership change notice | ASX |
|---|
| Change of Director's Interest Notice | Aug 28, 2026 | Ownership change notice | ASX |
|---|
| Full year results announcement FY26 | Aug 27, 2026 | Results | ASX |
|---|
| Full Year Statutory Accounts | Aug 27, 2026 | Annual report | ASX |
|---|
| Securities Trading Policy | Aug 27, 2026 | Other filings | ASX |
|---|
| Corporate Governance Statement | Aug 27, 2026 | Other filings | ASX |
|---|
| Appendix 4G | Aug 27, 2026 | Other filings | ASX |
|---|
| Investor presentation | Aug 27, 2026 | Other filings | ASX |
|---|
| Notification of cessation of securities - SOM | Aug 25, 2026 | Notification letter | ASX |
|---|
| FY26 Results announcement date and Webinar Invitation | Aug 18, 2026 | Other filings | ASX |
|---|
| Securities Trading Policy | Aug 14, 2026 | Other filings | ASX |
|---|
| Executive management update & unaudited FY26 results | Jul 27, 2026 | Other filings | ASX |
|---|
| Investor presentation | Feb 26, 2026 | Other filings | ASX |
|---|
| Half Yearly Report and Accounts | Feb 26, 2026 | Interim report | ASX |
|---|
| Half year results announcement FY26 | Feb 26, 2026 | Interim report | ASX |
|---|
| AGM Investor Presentation & addresses | Nov 27, 2025 | Other filings | ASX |
|---|
| Quarterly Update | Oct 29, 2025 | Other filings | ASX |
|---|
| Annual Report & full year results | Aug 27, 2025 | Annual report | ASX |
|---|
| Full year results announcement FY25 | Aug 27, 2025 | Results | ASX |
|---|
| Quarterly Cashflow Report | Jul 28, 2025 | Quarterly report | ASX |
|---|
| Quarterly Activities Report | Jul 28, 2025 | Quarterly report | ASX |
|---|
| United States of America tariff update | Apr 7, 2025 | Other filings | ASX |
|---|
| FY25 Half Year Results | Feb 27, 2025 | Interim report | ASX |
|---|
| Quarterly Appendix 4C Cash Flow Report | Jan 23, 2025 | Quarterly report | ASX |
|---|
| FY25 Guidance Update and Quarterly Report | Jan 23, 2025 | Quarterly report | ASX |
|---|
| AGM Chairman & co-CEO addresses | Nov 26, 2024 | Other filings | ASX |
|---|
| Investor Presentation AGM | Nov 26, 2024 | Other filings | ASX |
|---|
| FY25 Guidance Upgrade and Appointment of CFO | Nov 26, 2024 | Guidance | ASX |
|---|
| Rest Assure - US Food and Drug Authority (FDA) Update | Oct 6, 2024 | Other filings | ASX |
|---|
| Investor Presentation | Aug 27, 2024 | Other filings | ASX |
|---|
| FY24 Preliminary Report and FY25 Guidance | Aug 27, 2024 | Guidance | ASX |
|---|
| Preliminary Final Report | Aug 27, 2024 | Results | ASX |
|---|
| Completion of retail component of Entitlement Offer | May 3, 2024 | Financing | ASX |
|---|
| Replacement Prospectus | Apr 15, 2024 | Offer document | ASX |
|---|
| Reinstatement to Quotation | Apr 10, 2024 | Trading halt or suspension | ASX |
|---|
| Completion of institutional component of Entitlement Offer | Apr 10, 2024 | Financing | ASX |
|---|
| Prospectus Entitlement Offer | Apr 8, 2024 | Offer document | ASX |
|---|
| Revised guidance and capital raising | Apr 8, 2024 | Guidance | ASX |
|---|
| Update on voluntary suspension & FY24 earnings guidance | Apr 4, 2024 | Guidance | ASX |
|---|
| Suspension from Quotation | Apr 2, 2024 | Trading halt or suspension | ASX |
|---|
| Trading Halt | Mar 26, 2024 | Trading halt or suspension | ASX |
|---|
| Solid start in 1H as core business revenues increase 13% | Feb 27, 2024 | Other filings | ASX |
|---|
| Appointment of Co-CEO's | Feb 22, 2024 | Management or board change | ASX |
|---|
| AGM presentation | Nov 24, 2023 | Other filings | ASX |
|---|
| AGM Chairman & CEO addresses | Nov 24, 2023 | Meeting outcome | ASX |
|---|
| Quarterly cash report | Oct 29, 2023 | Quarterly report | ASX |
|---|
| Results of Retail Entitlement Offer | Sep 25, 2023 | Financing | ASX |
|---|
| Successful completion of institutional Offer and Placement | Sep 3, 2023 | Financing | ASX |
|---|
| FY23 results and Capital raising | Aug 30, 2023 | Results | ASX |
|---|
| Appendix 4C | Jul 25, 2023 | Quarterly report | ASX |
|---|
| Appendix 4C - March 2023 | Apr 27, 2023 | Quarterly report | ASX |
|---|
| Growth momentum maintained | Apr 27, 2023 | Other filings | ASX |
|---|
| Revenue growth momentum continues in 1H FY23 | Feb 22, 2023 | Other filings | ASX |
|---|
| Updated Quarterly Activities | Feb 1, 2023 | Quarterly report | ASX |
|---|
| Appendix 4C - December 2022 | Jan 29, 2023 | Quarterly report | ASX |
|---|
| Second quarter revenue growth of 17% to $21.4 million | Jan 29, 2023 | Other filings | ASX |
|---|
| AGM Chairman and CEO addresses | Nov 24, 2022 | Other filings | ASX |
|---|
| AGM Investor Presentation | Nov 24, 2022 | Other filings | ASX |
|---|
| Appendix 4C....typographical correction | Oct 26, 2022 | Quarterly report | ASX |
|---|
| Appendix 4C Cash Flow Report | Oct 24, 2022 | Quarterly report | ASX |
|---|
| North America Q1 revenue growth leads the way | Oct 24, 2022 | Other filings | ASX |
|---|
| FY22 results and FY23 guidance | Aug 22, 2022 | Guidance | ASX |
|---|
| Quarterly Cash Flow Report | Jul 25, 2022 | Quarterly report | ASX |
|---|
| Record Q4 and delivers on FY22 revenue guidance | Jul 25, 2022 | Guidance | ASX |
|---|
| Strong revenue growth and continued positive momentum | Apr 26, 2022 | Other filings | ASX |
|---|
| Revenues on track despite COVID-19 disruptions | Feb 21, 2022 | Other filings | ASX |
|---|
| World first technology enabled oral appliance | Jan 30, 2022 | Other filings | ASX |
|---|
| North America Q2 revenue 36% amid regional variability | Jan 26, 2022 | Other filings | ASX |
|---|
| Quarterly - revenue growth in key markets gains momentum | Oct 25, 2021 | Other filings | ASX |
|---|
| Appendix 4C - quarterly | Jul 26, 2021 | Quarterly report | ASX |
|---|
| Quarterly activities - Strong Q4 provides momentum into FY22 | Jul 26, 2021 | Quarterly report | ASX |
|---|
| Trading and operational activities improved over the quarter | Apr 26, 2021 | Other filings | ASX |
|---|
| S&P DJI Announces March 2021 Quarterly Rebalance | Mar 12, 2021 | Other filings | ASX |
|---|
| H1 FY21 SomnoMed Media Release | Feb 22, 2021 | Other filings | ASX |
|---|
| $17m of revenue delivered for the December Quarter FY21 | Jan 27, 2021 | Other filings | ASX |
|---|
| AGM Presentation and addresses | Nov 26, 2020 | Other filings | ASX |
|---|
| Improved quarterly performance | Oct 20, 2020 | Other filings | ASX |
|---|
| SomnoMed appoints new Directors | Aug 20, 2020 | Management or board change | ASX |
|---|
| Positive trends for Q4 in the midst of a global pandemic | Jul 22, 2020 | Other filings | ASX |
|---|
| S&P DJI Announces June 2020 Quarterly Rebalance | Jun 11, 2020 | Other filings | ASX |
|---|
| Trading update | Jun 1, 2020 | Other filings | ASX |
|---|
| Satisfactory Q3 despite COVID-19 affected March | Apr 26, 2020 | Other filings | ASX |
|---|
| Retail Entitlement Offer Booklet | Mar 31, 2020 | Financing | ASX |
|---|
| Reinstatement to Official Quotation | Mar 25, 2020 | Trading halt or suspension | ASX |
|---|
| Results of Institutional Offer | Mar 25, 2020 | Other filings | ASX |
|---|
| Trading Update and Entitlement Offer | Mar 24, 2020 | Financing | ASX |
|---|
| Suspension from Official Quotation | Mar 18, 2020 | Trading halt or suspension | ASX |
|---|
| Pause in Trading | Mar 17, 2020 | Trading halt or suspension | ASX |
|---|
| Half Year Accounts | Feb 17, 2020 | Interim report | ASX |
|---|
| Core revenue growth up 19% in Q2 | Jan 27, 2020 | Other filings | ASX |
|---|
| Strong North American revenue growth in Q1 | Oct 27, 2019 | Other filings | ASX |
|---|
| North American direct revenues up 31% in Q4 | Jul 23, 2019 | Other filings | ASX |
|---|
| 500,000 patients treated worldwide | Jul 8, 2019 | Other filings | ASX |
|---|
| Core revenue growth up 9% in Q3 | Apr 28, 2019 | Other filings | ASX |
|---|
| S&P DJI Announces March 2019 Quarterly Rebalance | Mar 7, 2019 | Other filings | ASX |
|---|
| Core revenue growth up 13% in Q2 | Jan 28, 2019 | Other filings | ASX |
|---|
| 2018 AGM addresses - Chairman and CEO | Nov 26, 2018 | Other filings | ASX |
|---|
| Change in Leadership of SomnoMed | Nov 18, 2018 | Other filings | ASX |
|---|
| Response to Appendix 4C Query | Nov 4, 2018 | Quarterly report | ASX |
|---|
| Strong first quarter in Core business diluted by RSS results | Oct 25, 2018 | Other filings | ASX |
|---|
| Full year results and the consolidation of RSS operations | Aug 21, 2018 | Results | ASX |
|---|
| SomnoMed posts 30% revenue growth for FY2018 | Jul 24, 2018 | Other filings | ASX |
|---|
| Trading Update | May 24, 2018 | Other filings | ASX |
|---|
| Retail Entitlement Offer Information Booklet | Feb 20, 2018 | Financing | ASX |
|---|
| Successful completion of Institutional Entitlement Offer | Feb 20, 2018 | Financing | ASX |
|---|
| Accelerated non-renounceable entitlement offer | Feb 18, 2018 | Financing | ASX |
|---|
| ASX Market Release - Trading Halt | Feb 18, 2018 | Trading halt or suspension | ASX |
|---|
| Revenue growth up 45% in Q2 | Jan 23, 2018 | Other filings | ASX |
|---|
| Good revenue growth for the quarter | Oct 25, 2017 | Other filings | ASX |
|---|
| Strong Q4 growth to finish transitional year | Jul 24, 2017 | Other filings | ASX |
|---|
| Renew Sleep Solutions well ahead of plan | Apr 25, 2017 | Other filings | ASX |
|---|
| Renew Sleep Solutions opens first two centres in Q2 | Jan 22, 2017 | Other filings | ASX |
|---|
| Sales growth accelerating | Oct 17, 2016 | Other filings | ASX |
|---|
| FDA 510k approval for SomnoDent Alpha | Sep 21, 2016 | Other filings | ASX |
|---|
| Strong finish to the financial year for SomnoMed | Jul 21, 2016 | Other filings | ASX |
|---|
| Derek Smith appointed Global CEO of SomnoMed | Jul 18, 2016 | Other filings | ASX |
|---|
| Results of Institutional Entitlement Offer | May 4, 2016 | Financing | ASX |
|---|
| Chairmans Letter | May 2, 2016 | Other filings | ASX |
|---|
| Continuing High Growth in the Third Quarter | Apr 20, 2016 | Other filings | ASX |
|---|
| SomnoMed continues to break records in 4th Quarter | Mar 30, 2016 | Other filings | ASX |
|---|
| SomnoMed Accelerates Growth beyond Forecasts | Mar 30, 2016 | Other filings | ASX |
|---|
| SomnoMed posts new record in Q3 | Mar 30, 2016 | Other filings | ASX |
|---|
| CEO transfers to US | Mar 30, 2016 | Other filings | ASX |
|---|
| SomnoMed reports solid growth and stronger profits | Mar 30, 2016 | Other filings | ASX |
|---|
| SomnoMed finishes year with record quarter | Mar 30, 2016 | Other filings | ASX |
|---|
| Somnomed expands business and operations in Europe | Mar 30, 2016 | Other filings | ASX |
|---|
| Partnership with Sleep HealthCenters | Mar 30, 2016 | Other filings | ASX |
|---|
| SomnoDent G2 FDA 510(k) cleared | Mar 30, 2016 | Other filings | ASX |
|---|
| US Medical Expansion | Mar 30, 2016 | Other filings | ASX |
|---|
| Strong Global Sales Growth continues in Second Quarter | Mar 30, 2016 | Other filings | ASX |
|---|
| Acquisition of Dutch Oral Appliance Distribution Company | Mar 30, 2016 | Acquisition or disposal | ASX |
|---|
| US Medicare PDAC registration approved | Mar 30, 2016 | Other filings | ASX |
|---|
| 30% growth of direct sales revenues of Somnodent devices | Feb 11, 2016 | Other filings | ASX |
|---|
| SomnoMed exceeds 250,000 patients | Feb 10, 2016 | Other filings | ASX |
|---|
| Growth acceleration in the US leads to new record quarter | Feb 10, 2016 | Other filings | ASX |
|---|
| FDA approves SomnoDent wearable compliance micro-recording | Feb 10, 2016 | Other filings | ASX |
|---|
| SomnoMed to acquire 100% of SMH Biomaterial AG | Feb 10, 2016 | Acquisition or disposal | ASX |
|---|
| SomnoMed update | Feb 10, 2016 | Other filings | ASX |
|---|
| Continuous growth of SomnoMed in third quarter | Feb 10, 2016 | Other filings | ASX |
|---|
| S&P DJ Indices Announces March Quarterly Review | Feb 10, 2016 | Other filings | ASX |
|---|
| SomnoMed exceeds 200,000 patients | Feb 10, 2016 | Other filings | ASX |
|---|
| New records in September confirm guidance | Feb 10, 2016 | Guidance | ASX |
|---|
| Share Purchase Plan Offer and Rules | Feb 10, 2016 | Financing | ASX |
|---|
| Share Placement and 2014 Share Purchase Plan | Feb 10, 2016 | Financing | ASX |
|---|
| New sales records in Q4 & increasing growth prospects14/15 | Feb 10, 2016 | Other filings | ASX |
|---|
| SomnoMed takes over Italian Distribution | Feb 10, 2016 | Other filings | ASX |
|---|
| SomnoMed USA receives 510K for Somnodent Fusion | Feb 10, 2016 | Other filings | ASX |
|---|
| SomnoMed starts business in Spain and Portugal | Feb 10, 2016 | Other filings | ASX |
|---|
| SomnoMed enters UK - Ireland market | Feb 10, 2016 | Other filings | ASX |
|---|
| SomnoMed commences business in Finland | Feb 10, 2016 | Other filings | ASX |
|---|
| SomnoMed achieves 28% volume growth in Q3 | Feb 10, 2016 | Other filings | ASX |
|---|
| SomnoMed accelerates growth in Q2 | Feb 10, 2016 | Other filings | ASX |
|---|
| SomnoMed exceeds 150,000 patients wordwide | Feb 10, 2016 | Other filings | ASX |
|---|
| SomnoMed expands in Korea | Feb 10, 2016 | Other filings | ASX |
|---|
| SomnoMed posts strong cash position | Feb 10, 2016 | Other filings | ASX |
|---|
| SomnoMed acquires Orthosleep19 in Germany | Feb 10, 2016 | Acquisition or disposal | ASX |
|---|
| SomnoMed breaks through 10,000 unit sales in 4th Quarter | Feb 10, 2016 | Other filings | ASX |
|---|
| Progress in USA | Feb 10, 2016 | Other filings | ASX |
|---|
| Strong European growth and new US management team in place | Feb 10, 2016 | Other filings | ASX |
|---|
| SomnoMed delivers a record Second Quarter | Feb 10, 2016 | Other filings | ASX |
|---|
| SomnoMed acquires MAS Nordic | Feb 10, 2016 | Acquisition or disposal | ASX |
|---|
| Compliance measurement - exclusive agreement signed | Feb 10, 2016 | Other filings | ASX |
|---|
| Acquisition of Orthosom in France completed | Feb 10, 2016 | Acquisition or disposal | ASX |
|---|
| Acquisition of 2nd largest oral appliance company in France | Feb 10, 2016 | Acquisition or disposal | ASX |
|---|
| Partnership with Burkhart Dental Supply | Feb 10, 2016 | Other filings | ASX |
|---|
| SomnoMed MATRx receives FDA 510(k) clearance | Feb 10, 2016 | Other filings | ASX |
|---|
| Half Year Report and Accounts | Feb 10, 2016 | Interim report | ASX |
|---|
| SomnoMed Announces Sleep Apnea Management Program | Feb 10, 2016 | Other filings | ASX |
|---|
| Somnomed introduces new Medical product | Feb 10, 2016 | Other filings | ASX |
|---|
| Launch of new product line to treat Sleep Bruxism | Feb 10, 2016 | Other filings | ASX |
|---|